Published in Microb Drug Resist on March 28, 2012
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev (2015) 1.81
MexXY multidrug efflux system of Pseudomonas aeruginosa. Front Microbiol (2012) 1.11
Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates. Antimicrob Agents Chemother (2016) 0.98
Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2016) 0.76
Characterization of a Carbapenem-Hydrolyzing Enzyme, PoxB, in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother (2015) 0.75
Intraclonal Genome Stability of the Metallo-β-lactamase SPM-1-producing Pseudomonas aeruginosa ST277, an Endemic Clone Disseminated in Brazilian Hospitals. Front Microbiol (2016) 0.75
Multicenter Evaluation of Ceftazidime-avibactam and Ceftolozane-tazobactam Inhibitory Activity against Meropenem Non-Susceptible P. aeruginosa from Blood, Respiratory Tract and Wounds. Antimicrob Agents Chemother (2017) 0.75
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis (2004) 20.99
Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother (2002) 4.80
Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis (2010) 4.25
Antibiotic prevention of acute exacerbations of COPD. N Engl J Med (2012) 4.11
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis (2003) 3.53
Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J Clin Microbiol (2006) 3.30
Managing SARS amidst uncertainty. N Engl J Med (2003) 2.87
Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J Antimicrob Chemother (2009) 2.56
Screening inpatients for MRSA--case closed. N Engl J Med (2013) 2.44
Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol (2008) 2.27
Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J (2003) 2.22
Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther (2010) 1.99
Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis (2002) 1.83
Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil. Antimicrob Agents Chemother (2009) 1.75
Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol (2008) 1.74
Positive deviance: a new strategy for improving hand hygiene compliance. Infect Control Hosp Epidemiol (2010) 1.64
Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. J Infect (2011) 1.61
SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infect Dis (2004) 1.58
Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol (2011) 1.54
Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis (2005) 1.54
Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms. BMC Genomics (2014) 1.48
Infections associated with religious rituals. Int J Infect Dis (2013) 1.44
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. J Infect (2005) 1.43
First isolation of metallo-beta-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil. J Clin Microbiol (2005) 1.41
Patient-to-patient transmission of hepatitis C virus. Ann Intern Med (2005) 1.40
Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting. PLoS One (2011) 1.35
Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines? Mem Inst Oswaldo Cruz (2006) 1.34
Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). J Antimicrob Chemother (2003) 1.34
Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect Dis (2006) 1.31
OXA-72-producing Acinetobacter baumannii in Brazil: a case report. J Antimicrob Chemother (2010) 1.31
Septic shock--evaluating another failed treatment. N Engl J Med (2012) 1.30
The route of antimicrobial resistance from the hospital effluent to the environment: focus on the occurrence of KPC-producing Aeromonas spp. and Enterobacteriaceae in sewage. Diagn Microbiol Infect Dis (2013) 1.30
Polymyxin-resistant Acinetobacter spp. isolates: what is next? Emerg Infect Dis (2003) 1.25
Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis (2007) 1.22
Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000). Int J Antimicrob Agents (2003) 1.22
Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis (2007) 1.17
Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis (2013) 1.17
Successful prevention of ventilator-associated pneumonia in an intensive care setting. Am J Infect Control (2009) 1.16
SPM-1-producing Pseudomonas aeruginosa: analysis of the ancestor relationship using multilocus sequence typing, pulsed-field gel electrophoresis, and automated ribotyping. Microb Drug Resist (2011) 1.13
Prevalence of community-occurring extended spectrum beta-lactamase-producing Enterobacteriaceae in Brazil. Curr Microbiol (2007) 1.12
Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis (2004) 1.12
Emergence of the extended-spectrum beta-lactamase GES-1 in a Pseudomonas aeruginosa strain from Brazil: report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother (2004) 1.11
Measuring rates of hand hygiene adherence in the intensive care setting: a comparative study of direct observation, product usage, and electronic counting devices. Infect Control Hosp Epidemiol (2010) 1.11
Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature. Clin Infect Dis (2005) 1.11
Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol (2007) 1.10
Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother (2006) 1.08
Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr (2007) 1.08
Is the cefoxitin disk test reliable enough to detect oxacillin resistance in coagulase-negative staphylococci? J Clin Microbiol (2005) 1.07
Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil. BMC Microbiol (2010) 1.07
Advances in the microbiological diagnosis of sepsis. Shock (2008) 1.06
Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era. Am J Infect Control (2010) 1.06
Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection. J Clin Microbiol (2006) 1.06
Post-malaria neurological syndrome: a case report and review of the literature. J Travel Med (2009) 1.05
Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance. Antimicrob Agents Chemother (2002) 1.05
Dissemination of IMP-1 metallo- beta -lactamase-producing Acinetobacter species in a Brazilian teaching hospital. Infect Control Hosp Epidemiol (2006) 1.04
Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). Braz J Infect Dis (2013) 1.04
Detection of SPM-1-producing Pseudomonas aeruginosa and class D β-lactamase-producing Acinetobacter baumannii isolates by use of liquid chromatography-mass spectrometry and matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2012) 1.03
A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms. Am J Infect Control (2007) 1.02
A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting. BMC Infect Dis (2012) 1.02
Bloodstream infection after kidney transplantation: epidemiology, microbiology, associated risk factors, and outcome. Transplantation (2010) 1.01
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci. BMC Infect Dis (2006) 1.01
Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control. Int J Antimicrob Agents (2007) 0.98
Low prevalence of blaOXA-143 in private hospitals in Brazil. Antimicrob Agents Chemother (2011) 0.97
Team-based prevention of catheter-related infections. N Engl J Med (2006) 0.96
Positive deviance: a program for sustained improvement in hand hygiene compliance. Am J Infect Control (2011) 0.95
Outbreak of OXY-2-Producing Klebsiella oxytoca in a renal transplant unit. J Clin Microbiol (2008) 0.95
Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 0.95
Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations. Antimicrob Agents Chemother (2013) 0.95
Detection of GES-5-producing Klebsiella pneumoniae in Brazil. J Antimicrob Chemother (2010) 0.94
Detection of OXA-231, a new variant of blaOXA-143, in Acinetobacter baumannii from Brazil: a case report. J Antimicrob Chemother (2012) 0.93
A multicenter study using positive deviance for improving hand hygiene compliance. Am J Infect Control (2013) 0.92
Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. BMC Infect Dis (2006) 0.92
Molecular typing and antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium in Brazil. Infect Control Hosp Epidemiol (2002) 0.92
Influence of disk preparation on detection of metallo-beta-lactamase-producing isolates by the combined disk assay. J Clin Microbiol (2007) 0.92
Cation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results. J Clin Microbiol (2012) 0.91
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use. Emerg Infect Dis (2005) 0.90
Emergence of Klebsiella pneumoniae-producing KPC-2 carbapenemase in Paraíba, Northeastern Brazil. Braz J Infect Dis (2012) 0.89
Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit. Infect Control Hosp Epidemiol (2012) 0.89
Comment on: Performance of the Oxoid M.I.C.Evaluator™ Strips compared with the Etest® assay and BSAC agar dilution. J Antimicrob Chemother (2011) 0.89
Nosocomial bloodstream infections in Brazilian pediatric patients: microbiology, epidemiology, and clinical features. PLoS One (2013) 0.88
Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis (2010) 0.88
Influence of state laws mandating reporting of healthcare-associated infections: the case of central line-associated bloodstream infections. Infect Control Hosp Epidemiol (2013) 0.88
Practices and an assessment of health care workers' perceptions of compliance with infection control knowledge of nosocomial infections. Am J Infect Control (2005) 0.87
Clonal complex 258, the most frequently found multilocus sequence type complex in KPC-2-producing Klebsiella pneumoniae isolated in Brazilian hospitals. Antimicrob Agents Chemother (2012) 0.87
Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections. J Clin Microbiol (2002) 0.87
Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit. Infect Control Hosp Epidemiol (2010) 0.87
Controlled trial measuring the effect of a feedback intervention on hand hygiene compliance in a step-down unit. Infect Control Hosp Epidemiol (2008) 0.86
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America. Antimicrob Agents Chemother (2007) 0.86
Surgeons do not listen: evaluation of compliance with antimicrobial stewardship program recommendations. Am Surg (2013) 0.85
Targeted decolonization to prevent ICU infections. N Engl J Med (2013) 0.84
Evaluation of the susceptibility profiles, genetic similarity and presence of qnr gene in Escherichia coli resistant to ciprofloxacin isolated in Brazilian hospitals. Braz J Infect Dis (2007) 0.84
Dissemination of bla(IMP-1)-carrying integron In86 among Klebsiella pneumoniae isolates harboring a new trimethoprim resistance gene dfr23. Diagn Microbiol Infect Dis (2008) 0.84
Effect of contact precautions on wait time from emergency room disposition to inpatient admission. Infect Control Hosp Epidemiol (2011) 0.84
First description of KPC-2-producing Klebsiella oxytoca in Brazil. Antimicrob Agents Chemother (2013) 0.83